Sido Muncul Overview

  • Year Founded
  • 1951

Year Founded

  • Status
  • Public

  • Employees
  • 3,468

Employees

  • Stock Symbol
  • SIDO

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.04
  • (As of Tuesday Closing)

Sido Muncul General Information

Description

PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Food Products
Personal Products
Stock Exchange
IDX
Corporate Office
  • Tentrem Hotel Building Jalan Legian Gajahmada No. 123
  • 1st Floor
  • Semarang, 50134
  • Indonesia
+62 (024) 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sido Muncul Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.03 - $0.06 $1.32B 30B 45.8M

Sido Muncul Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 958,685 958,685 1,392,855 1,744,086
Revenue 233,743 233,743 260,022 279,977
EBITDA 84,850 84,850 100,117 116,316
Net Income 62,314 62,314 74,311 87,795
Total Assets 249,165 249,165 262,339 284,567
Total Debt 601 601 153 606
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sido Muncul Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sido Muncul‘s full profile, request access.

Request a free trial

Sido Muncul Executive Team (1)

Name Title Board Seat Contact Info
Leonard Leo Chief Financial Officer
To view Sido Muncul’s complete executive team members history, request access »

Sido Muncul Board Members (6)

Name Representing Role Since
00000 0000000 Sido Muncul Board Member 000 0000
0000000 0000000 Sido Muncul Chairman & Board Member 000 0000
000000000 0000 00. Sido Muncul Independent Commissioner, Board of Commissioner 000 0000
000000 00000 Sido Muncul Board Member 000 0000
00000 0000000 Sido Muncul Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Sido Muncul Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sido Muncul Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sido Muncul‘s full profile, request access.

Request a free trial

Sido Muncul Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PT. Berlico Mulia Farma 01-Sep-2014 0000000000 Pharmaceuticals 0000000 0
To view Sido Muncul’s complete acquisitions history, request access »

Sido Muncul ESG

Risk Overview

Risk Rating

Updated December, 20, 2022

19.06 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,173

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 909

Rank

0.00

Percentile

Pharmaceuticals

Subindustry

00 of 444

Rank

0.00

Percentile

To view Sido Muncul’s complete esg history, request access »

Sido Muncul FAQs

  • When was Sido Muncul founded?

    Sido Muncul was founded in 1951.

  • Where is Sido Muncul headquartered?

    Sido Muncul is headquartered in Semarang, Indonesia.

  • What is the size of Sido Muncul?

    Sido Muncul has 3,468 total employees.

  • What industry is Sido Muncul in?

    Sido Muncul’s primary industry is Pharmaceuticals.

  • Is Sido Muncul a private or public company?

    Sido Muncul is a Public company.

  • What is Sido Muncul’s stock symbol?

    The ticker symbol for Sido Muncul is SIDO.

  • What is the current stock price of Sido Muncul?

    As of 23-Apr-2024 the stock price of Sido Muncul is $0.04.

  • What is the current market cap of Sido Muncul?

    The current market capitalization of Sido Muncul is $1.32B.

  • What is Sido Muncul’s current revenue?

    The trailing twelve month revenue for Sido Muncul is $234M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »